Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis
- 1 July 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Oncology
- Vol. 24 (4), 363-370
- https://doi.org/10.1097/cco.0b013e328352eaa3
Abstract
Purpose of review To discuss the promising state of the art low-level laser therapy (LLLT) for preventive and therapeutic usage in oral mucositis due to cancer therapy. Recent findings Photomedicine using LLLT is very effective with intraoral and extraoral devices in the management of oral mucositis, based on several studies including randomized control studies. A systematic review identified 33 relevant articles that were subjected to meta-analysis based on which laser parameters in routine practice are being defined. Meta-analysis showed that LLLT reduced risk of oral mucositis with relative risk (RR) 2.45 [confidence interval (CI) 1.85-3.18], reduced duration, severity of oral mucositis and reduced number of days with oral mucositis (4.38 days, P찮0009). RR was similar between the red (630-670 nm) and infrared (780-830 nm) LLLT. Pain-relieving effect based on the Cohen scale was at 1.22 (CI 0.19-2.25). Summary No adverse side effects of LLLT were reported; hence, we recommend red or infrared LLLT with diode output between 10-100mW, dose of 2-3 J/cm2/cm2 for prophylaxis and 4 J/cm2 (maximum limit) for therapeutic effect, application on single spot rather than scanning motion. Lesions must be evaluated by a trained clinician and therapy should be repeated daily or every other day or a minimum of three times per week until resolution. There is moderate-to-strong evidence in favor of LLLT at optimal doses as a well tolerated, relatively inexpensive intervention for cancer therapy-induced oral mucositis. It is envisaged that LLLT will soon become part of routine oral supportive care in cancer.No Full TexThis publication has 42 references indexed in Scilit:
- A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositisSupportive Care in Cancer, 2011
- Low Level Laser Treatment of Tendinopathy: A Systematic Review with Meta-analysisPhotomedicine and Laser Surgery, 2010
- Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trialsThe Lancet, 2009
- Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy‐induced oral mucositis: Comparison between low and high/low power lasersLasers in Surgery and Medicine, 2009
- The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studiesSupportive Care in Cancer, 2008
- A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 2006
- The short‐term effects of low‐level lasers as adjunct therapy in the treatment of periodontal inflammationJournal of Clinical Periodontology, 2005
- NASA Light-Emitting Diodes for the Prevention of Oral Mucositis in Pediatric Bone Marrow Transplant PatientsJournal of Clinical Laser Medicine & Surgery, 2002
- Low-energy He/Ne laser in the prevention of radiation-induced mucositisSupportive Care in Cancer, 1999
- Low intensity laser therapy: Still not an established clinical toolLasers in Surgery and Medicine, 1995